Quarterly report pursuant to Section 13 or 15(d)

8. Segment and Geographic Information

v2.4.0.8
8. Segment and Geographic Information
3 Months Ended
Jun. 30, 2013
Segment Reporting [Abstract]  
8. Segment and Geographic Information

The Company generates product revenues from wound care products which are sold into the human and animal healthcare markets, and the Company generates service revenues from laboratory testing services which are provided to medical device manufacturers.

 

The Company operates a single segment business for product sales which consists of three geographical sales territories as follows (in thousands):

 

    Three Months Ended
June 30,
 
    2013     2012  
U.S.   $ 1,323     $ 2,033  
Mexico     1,424       1,378  
Europe and other     407       405  
    $ 3,154     $ 3,816  

 

For the three months ended June 30, 2013 and 2012, the Company recorded licensing revenues of $433,000 and $12,000, respectively. Such revenues are reflected in the table above within product revenue under the respective geographic region where such licensing revenues were earned.

 

The Company’s service revenues amounted to $218,000 and $235,000 for the three months ended June 30, 2013 and 2012.